A detailed history of New York State Common Retirement Fund transactions in Adma Biologics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 255,569 shares of ADMA stock, worth $4.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
255,569
Previous 247,697 3.18%
Holding current value
$4.45 Million
Previous $2.77 Million 84.51%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$11.21 - $20.03 $88,245 - $157,676
7,872 Added 3.18%
255,569 $5.11 Million
Q2 2024

Jul 31, 2024

BUY
$5.98 - $11.18 $69,230 - $129,430
11,577 Added 4.9%
247,697 $2.77 Million
Q1 2024

May 07, 2024

BUY
$4.4 - $6.74 $657,659 - $1.01 Million
149,468 Added 172.49%
236,120 $1.56 Million
Q4 2023

Feb 01, 2024

BUY
$3.08 - $4.52 $74,021 - $108,629
24,033 Added 38.38%
86,652 $392,000
Q3 2023

Nov 07, 2023

BUY
$3.47 - $4.61 $1,981 - $2,632
571 Added 0.92%
62,619 $224,000
Q2 2023

Aug 07, 2023

SELL
$3.12 - $4.22 $93,771 - $126,832
-30,055 Reduced 32.63%
62,048 $229,000
Q1 2023

May 02, 2023

SELL
$3.01 - $3.87 $113,558 - $146,003
-37,727 Reduced 29.06%
92,103 $305,000
Q4 2022

Jan 30, 2023

SELL
$2.47 - $3.88 $419 - $659
-170 Reduced 0.13%
129,830 $504,000
Q3 2022

Nov 08, 2022

BUY
$2.03 - $2.86 $3,450 - $4,862
1,700 Added 1.33%
130,000 $316,000
Q2 2022

Aug 04, 2022

BUY
$1.43 - $2.2 $183,469 - $282,260
128,300 New
128,300 $254,000
Q3 2021

Nov 02, 2021

SELL
$1.13 - $1.65 $540 - $788
-478 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$1.51 - $2.07 $60,433 - $82,845
-40,022 Reduced 98.82%
478 $1,000
Q3 2019

Nov 07, 2019

BUY
$3.19 - $5.39 $120,901 - $204,281
37,900 Added 1457.69%
40,500 $180,000
Q4 2018

Feb 08, 2019

SELL
$2.17 - $6.12 $40,145 - $113,220
-18,500 Reduced 87.68%
2,600 $6,000
Q2 2018

Aug 10, 2018

BUY
$4.39 - $5.44 $92,629 - $114,784
21,100 New
21,100 $95,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.